Outset Medical OM Cash Flow Statement (2019-2026)

NASDAQ OM
$4.17 -0.05 (-1.18%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Outset Medical Quarterly Cash Flow Statement

Periods 29 quarters
Latest Sep 2026

Outset Medical reported cash from operations of -$10.38M and free cash flow of -$10.49M for the quarter ended Sep 2026, down 64.2% year over year. This cash flow statement covers 29 quarters of results from Sep 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-41.23M-36.89M-43.84M-40.78M-41.49M-43.97M-44.05M-46.18M-38.60M-39.94M-34.45M-27.94M-25.66M-25.78M-18.54M-17.84M-19.50M-18.98M-17.98M-14.69M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
1.30M1.26M1.32M1.31M1.27M1.38M1.51M1.47M1.45M1.46M1.47M1.39M1.41M1.29M1.16M1.01M0.88M0.80M0.63M0.67M
Share-based CompensationStock Comp.
4.79M5.01M7.41M7.43M7.35M8.54M10.11M10.89M9.10M8.20M9.82M6.39M4.95M2.98M3.50M5.08M4.06M3.45M2.70M1.69M
Cash from Discontinued OperationsCash from Discont. Ops
-38.34M-38.58M-34.31M-44.76M-45.91M
Gains from Sales and DivestituresGains Divest
-0.08M-0.01M-0.01M-0.02M0.00M
Other non-cash itemsOther Non-Cash
0.74M0.91M0.76M1.23M2.58M1.61M0.78M0.58M0.86M1.40M0.97M13.00M1.20M1.18M
Change in Working Capital
Change in ReceivablesChange Receivables
6.30M1.30M-2.26M-2.12M5.59M6.22M2.70M-1.36M-2.47M3.50M-0.54M0.14M1.92M1.47M-0.57M-2.90M-1.77M-3.41M5.04M2.09M
Change in InventoryChange Inventory
4.12M4.18M11.13M2.38M-2.96M-2.87M-3.24M3.51M0.96M6.98M6.23M-0.23M-2.13M-3.69M-3.61M-3.00M-1.49M2.24M-2.34M-2.19M
Change in Account PayablesChange Payables
-0.92M3.28M-2.59M-1.26M-0.71M1.48M0.21M0.57M3.06M0.95M-1.49M-0.96M-0.44M-2.77M0.27M0.34M-1.13M0.87M2.97M-0.10M
Change in Accrued ExpensesChange Accrued Exp.
4.61M-11.47M2.32M3.48M2.25M-7.10M3.04M-0.05M1.49M-4.46M-2.82M0.95M1.16M-8.58M1.55M1.07M-0.12M2.17M1.32M0.28M
Change in Other Operating AssetsOther Assets Change
-1.14M-0.14M0.07M-0.66M1.94M-0.57M-0.63M0.76M-0.30M0.40M-1.60M-0.65M1.06M0.34M-0.81M0.11M1.30M-0.93M-0.86M0.12M
Change in Other Operating LiabilitiesOther Liabilities Change
1.54M0.03M0.47M-0.27M0.71M-0.02M2.06M-0.44M0.16M0.31M-1.18M-0.85M0.12M-0.04M-0.52M0.64M-1.95M-1.63M0.39M-0.78M
Other Working Capital ChangesOther WC Changes
2.68M0.17M0.40M0.38M-1.24M0.55M2.69M-1.19M0.46M-0.09M0.42M-0.19M-0.95M-0.38M0.29M0.54M-3.25M-0.70M1.24M-0.90M
Cash from OperationsCash from Ops.
-32.68M-38.34M-38.58M-34.31M-34.51M-44.76M-28.18M-34.00M-24.44M-45.91M-33.34M-20.57M-16.49M-25.66M-4.82M-6.32M-9.52M-12.84M-9.64M-10.38M
Investing Activities
Capital ExpendituresCapex
0.85M1.48M2.00M2.74M2.11M0.81M0.80M0.78M1.05M0.35M0.12M0.40M0.04M0.12M0.29M0.16M0.22M0.07M0.11M0.11M
Change in Property, Plant and EquipmentChange in PP&E
-0.85M-1.48M-2.00M-2.74M-2.11M-0.81M-0.80M-0.78M-1.05M-0.35M-0.12M-0.40M-0.04M-0.12M-0.29M-0.16M-0.22M-0.07M-0.11M-0.11M
Purchase of InvestmentsInvestments Purchased
30.30M64.71M68.30M35.60M92.54M68.15M29.70M23.41M51.02M98.65M29.79M22.02M6.12M96.33M57.32M40.10M28.22M22.90M18.65M24.10M
Sale and Maturity of InvestmentsInvestments Sold
14.73M32.80M68.98M58.50M42.90M71.60M57.65M54.00M75.50M39.98M68.85M38.29M114.31M18.38M26.45M43.22M37.03M30.86M32.92M33.87M
Other Investing Activities (as filed)Other investing (as filed)
-33.39M-1.32M20.16M17.86M2.64M3.33M3.33M0.50M3.83M0.29M
Cash from Investing ActivitiesCash from Investing
-16.42M-33.39M-1.32M20.16M-51.75M2.64M27.15M29.81M23.43M-59.03M38.94M15.88M108.15M-78.08M-31.16M2.97M8.59M7.90M14.17M9.66M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
33.23M66.52M98.27M
Long-Term Debt RepaymentsLT Debt Repayment
0.01M0.09M0.14M
Net Long-Term Debt Issued (Repaid)Net LT Debt
33.23M66.52M98.27M-0.01M-0.09M-0.14M
Net Debt Issuances and RepaymentsNet Debt Issuance
33.23M66.52M98.27M-0.01M-0.09M-0.14M
Change in Capital Stock
Common Stock IssuedStock Issued
0.93M3.72M1.04M2.67M0.61M5.28M1.04M4.10M0.00M2.09M0.08M0.12M0.41M0.23M0.51M0.08M
Net Shares Issued and RepurchasedNet Shares Issued
0.93M3.72M1.04M2.67M0.61M5.28M1.04M4.10M0.00M2.09M0.08M0.12M0.41M0.23M0.51M0.08M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
161.93M-0.38M
Net Equity Issued and RepurchasedNet Equity Issued
0.93M3.72M1.04M2.67M0.61M5.28M1.04M4.10M0.00M2.09M0.08M0.12M162.34M-0.38M0.23M0.51M0.08M
Other financing activities (as filed)
0.14M
Cash from Financing ActivitiesCash from Financing
0.93M3.72M1.04M2.53M65.60M5.28M1.04M4.10M33.23M68.61M0.08M0.12M-0.94M55.66M-0.38M0.23M0.50M-0.09M-0.06M
Additional items
Change in Cash
-48.16M-68.00M-38.85M-11.62M-20.66M-36.84M0.02M-0.09M32.21M-36.33M5.68M-4.57M90.73M-48.09M-36.37M-3.12M-0.93M-4.44M4.44M-0.77M
Ending Cash Balance
215.66M147.66M108.81M97.19M76.53M39.70M39.72M39.63M71.84M35.51M41.19M36.62M127.34M79.26M42.89M39.77M38.84M34.39M38.83M38.06M
Free Cash FlowFCF
-33.53M-39.81M-40.57M-37.05M-36.62M-45.57M-28.97M-34.78M-25.50M-46.27M-33.46M-20.96M-16.53M-25.79M-5.12M-6.48M-9.74M-12.91M-9.75M-10.49M
Net Cash FlowNCF
-48.16M-68.00M-38.85M-11.62M-20.66M-36.84M0.02M-0.09M32.21M-36.33M5.68M-4.57M90.73M-48.09M-36.37M-3.12M-0.93M-4.44M4.44M-0.77M
Interest Paid
0.29M0.28M0.34M0.42M2.14M2.48M2.65M-3.30M9.01M4.92M5.18M5.44M5.15M7.36M2.78M2.77M2.73M2.67M2.71M2.75M
Income Taxes PaidTaxes Paid
0.01M0.21M0.08M0.05M0.05M0.20M0.11M0.09M0.09M0.26M0.10M0.12M0.12M0.11M0.10M0.12M0.12M0.40M0.27M0.20M

Outset Medical Cash Flow Statement API

Pull Outset Medical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=OM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY